rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2006-4-14
|
pubmed:abstractText |
The xenograft tumor mass in nude mice could be completely eliminated using the targeting dual gene-virotherapy strategy. Now, the most important point is to improve its security. This study was to construct dual cancer-specific targeting adenovirus called TD55 to evaluate its security, and construct TD55-TRAIL to explore its antitumor effect.
|
pubmed:language |
chi
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1000-467X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
385-92
|
pubmed:meshHeading |
pubmed-meshheading:16613667-Adenoviridae,
pubmed-meshheading:16613667-Adenovirus E1B Proteins,
pubmed-meshheading:16613667-Apoptosis,
pubmed-meshheading:16613667-Cell Line,
pubmed-meshheading:16613667-Cell Line, Tumor,
pubmed-meshheading:16613667-Gene Deletion,
pubmed-meshheading:16613667-Gene Targeting,
pubmed-meshheading:16613667-Genetic Vectors,
pubmed-meshheading:16613667-Humans,
pubmed-meshheading:16613667-Plasmids,
pubmed-meshheading:16613667-Promoter Regions, Genetic,
pubmed-meshheading:16613667-RNA, Messenger,
pubmed-meshheading:16613667-TNF-Related Apoptosis-Inducing Ligand,
pubmed-meshheading:16613667-Telomerase,
pubmed-meshheading:16613667-Transfection,
pubmed-meshheading:16613667-Virus Replication
|
pubmed:year |
2006
|
pubmed:articleTitle |
[Security of dual cancer-specific targeting vector and its cytotoxic effect when harbored].
|
pubmed:affiliation |
Xin Yuan Institute of Medicine and Biotechnology, School of Life Science, Zhejiang Sci-Tech University, Hangzhou, Zhejiang, PR China.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|